China Expanding Anti-Corruption Drive Across Health Sector
This article was originally published in PharmAsia News
Executive Summary
BEIJING - China's ongoing battle to curtail corruption was the topic of PharmAsia News' Aug. 27 audioconference, "Anti-Bribery Compliance in China - Avoiding the Pitfalls."
You may also be interested in...
CEO Of China's Leading Vaccine Producer Reveals Latest Vaccine Scandal Has Triggered A Sector-wide Boycott, Throwing Firm Into The Red
BEIJING - The chief executive officer of Sinovac Biotech, China's leading vaccine developer, told investors this week that the country's latest vaccine scandal had poisoned public perceptions so deeply that many citizens are boycotting the entire sector
CEO Of China's Leading Vaccine Producer Reveals Latest Vaccine Scandal Has Triggered A Sector-wide Boycott, Throwing Firm Into The Red
BEIJING - The chief executive officer of Sinovac Biotech, China's leading vaccine developer, told investors this week that the country's latest vaccine scandal had poisoned public perceptions so deeply that many citizens are boycotting the entire sector
U.S. Regulators Beef Up Investigation of Corporate Bribery & Corruption Overseas
Pharmaceutical companies have been battered by government and congressional investigations of their domestic marketing practices. They now face increased scrutiny on another front as the Department of Justice and the Securities and Exchange Commission are stepping up investigations of corporate corruption and bribery abroad